Error message

Notice: Undefined index: table in entity_views_plugin_row_entity_view->init() (line 20 of /var/www/public/sites/all/modules/contrib/entity/views/plugins/entity_views_plugin_row_entity_view.inc).

Publications

You are here

Title
Info
Link

2016

  1. Angiotensin-(1-7) with thioether-bridge: an ACE-resistant, potent Ang-(1-7) analogue.
    Kluskens, L.D., Nelemans, S.A., Rink, R., de Vries, L., Meter-Arkema, A., Wang, Y., Walther, T., Kuipers, A., Moll, G. N., and Haas, M. (2009), Pharmacol. Exper. Ther. 328, 849-854
  2. Production of dehydroamino acid-containing peptides by Lactococcus lactis. -
    Rink, R., Wierenga, J., Kuipers, A., Kluskens, L.D., Driessen, A.J., Kuipers, O.P., Moll, G.N. (2007). Appl. Environ. Microbiol. 73, 1792-1796.
  3. A biological stabilization technology for peptide drugs: enzymatic introduction of thioether-bridges.
    Moll, G.N. Kuipers, A., de Vries, L., Bosma, T., Rink, R. (2009), Drug Discov Today: Technol. doi:10.1016/j.ddtec.2009.03.001
  4. Sec-mediated transport of post-translationally Dehydrated Peptides in Lactococcus lactis. -
    Kuipers, A., Wierenga, J., Rink, R., Kluskens, L.D., Driessen, A.J.M., Kuipers O.P., and Moll, G.N. (2006), Appl. Environ. Microbiol. 72, 7626-7633
  5. Sec-mediated transport of post-translationally Dehydrated Peptides in Lactococcus lactis. -
    Kuipers, A., Wierenga, J., Rink, R., Kluskens, L.D., Driessen, A.J.M., Kuipers O.P., and Moll, G.N. (2006), Appl. Environ. Microbiol. 72, 7626-7633
  6. Oral and pulmonary delivery of thioether-bridged angiotensin-(1-7). -
    de Vries, L., Reitzema-Klein, C. E., Arkema-Meter, A., van Dam, A., Rink, R., Moll, G.N., Haas-Jimoh-Akanbi, M. (2010), Peptides 31, 893-898.
  7. Mechanistic dissection of the enzyme complexes involved in the biosynthesis of nisin and lacticin 3147. -
    Kuipers, A., Meijer-Wierenga, J., Rink, R., Kluskens, L.D., and Moll, G.N. (2008), Appl. Environ. Microbiol. 74, 6591-6597
  8. Angiotensin-(1-7) with thioether-bridge: an ACE-resistant, potent Ang-(1-7) analogue
    Kluskens, L.D., Nelemans, S.A., Rink, R., de Vries, L., Meter-Arkema, A., Wang, Y., Walther, T., Kuipers, A., Moll, G. N., and Haas, M. (2009), Pharmacol. Exper. Ther. 328, 849-854
  9. Production of dehydroamino acid-containing peptides by Lactococcus lactis. -
    Rink, R., Wierenga, J., Kuipers, A., Kluskens, L.D., Driessen, A.J., Kuipers, O.P., Moll, G.N. (2007). Appl. Environ. Microbiol. 73, 1792-1796.

2012

  1. Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury. -
    Wagenaar GT, Laghmani EH, Fidder M, Sengers RM, de Visser YP, de Vries L, Rink R, Roks AJ, Folkerts G, Walther FJ, (2012), Wagenaar GT, Laghmani EH, Fidder M, Sengers RM, de Visser YP, de Vries L, Rink R, Roks AJ, Folkerts G, Walther FJ, (2012)
  2. Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury. -
    Wagenaar GT, Laghmani EH, Fidder M, Sengers RM, de Visser YP, de Vries L, Rink R, Roks AJ, Folkerts G, Walther FJ, (2012), Wagenaar GT, Laghmani EH, Fidder M, Sengers RM, de Visser YP, de Vries L, Rink R, Roks AJ, Folkerts G, Walther FJ, (2012)

2011

  1. Genetics, biosynthesis, structure and mode of action of lantibiotics. In: Prokaryotic antimicobial peptides, from genes to applications. -
    Kuipers, A., Rink, R., Moll, G.N. (2011) . Eds. D. Drider, S. Rebuffat. Springer. p147-169.

2010

  1. Microbial production of thioether-stabilized peptides. -
    Kuipers, A. (2010),
  2. Microbial production of thioether-stabilized peptides. -
    Kuipers, A. (2010), Ph.D. Thesis. University of Groningen.
  3. To protect peptide pharmaceuticals against peptidases. -
    Rink, R., Arkema-Meter, A., Baudoin, I., Post, E., Kuipers, A., Nelemans, S.A., Haas-Jimoh-Akanbi, M., Moll, G.N. (2010), Pharmacol. Toxicol. Methods. 61, 210–218

Pages